Humanosphere is on hiatus. Many thanks to our web design, development and hosting partner Culture Foundry for keeping the site active while we plan our next move. Culture Foundry builds, evolves and supports next-level websites and applications for clients you know, and you couldn’t ask for a better partner to help you thrive in digital. If you’re considering an ambitious website design or development project, we encourage you to make them your very first call.

HIV Vaccine Awareness Day

by hitthatswitch, Flickr

It’s HIV Vaccine Awareness Day.

So you should, at the very least, be aware that for the first time in decades there’s optimism in the field of HIV vaccine research. We appear to be making progress.

I attended a big AIDS vaccine research meeting in Atlanta last fall, at which there was almost a kind of giddiness among scientists who for decades had been frustrated time after time, making little progress. A clinical trial in Thailand, run by the U.S. military in collaboration with Thai scientists, showed for the first time that a vaccine could prevent infection.

Yet the public, I bemoaned at the time, was barely paying any attention .

“This is an exciting time in HIV prevention research,” said Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition.

Most of the public attention is on advances in treatment, Warren said, though last week scientists showed that treatment is prevention by documenting (again) that getting HIV-infected on drugs helps prevent the spread of HIV — a finding that some say is a “gamechanger” in the global fight against HIV.

“At the same time, it is important that the progress in the search for an AIDS vaccine not be over-looked,” Warren said.


About Author

Tom Paulson

Tom Paulson is founder and lead journalist at Humanosphere. Prior to operating this online news site, he reported on science,  medicine, health policy, aid and development for the Seattle Post-Intelligencer. Contact him at tom[at] or follow him on Twitter @tompaulson.